Peptide directoryBrain, hypothalamus & pituitary

Galanin

A peptide of appetite, mood, pain and seizures, found in pig gut in 1983.

Where it comes from

Made in
Hypothalamus, locus coeruleus, dorsal root ganglia, pituitary, gut and pancreas
Sent out by
Fat intake, stress and nerve injury raise it
Acts on
  • Hypothalamus (feeding, especially fat)
  • Locus coeruleus (mood)
  • Hippocampus (memory)
  • Spinal cord (pain)
  • Islets (insulin)

What it does

  • Drives alcohol intake in rodents; its pull towards fat specifically failed to replicate in one laboratory 2
  • Holds down seizures in the hippocampus; it cuts acetylcholine release in the ventral hippocampus, though what that does to memory is disputed 2
  • Rises hugely in injured sensory neurons; in Alzheimer’s disease galanin fibres hyperinnervate the surviving cholinergic neurons, which now reads as protective 2

In medicine

  • No medicine copies it or blocks it. Galanin is a research marker in nerve injury and a drug target in epilepsy and depression 2
  • Its three receptors are the practical obstacle: GALR1, GALR2 and GALR3 do different things in the same brain, and no ligand selective enough to separate them has reached people 2

Beyond the body’s own use

  • Stabilised galanin analogues reduced seizure severity in animal models of epilepsy, though not in every model; the best studied of them worked after injection into the bloodstream, which plain galanin does not, and none has reached people 3
  • Variants of the galanin gene and of its GALR3 receptor were linked with alcohol dependence in two populations by one laboratory, and have not been replicated independently 2
  • Nothing containing galanin is approved or obtainable outside the laboratory. What is being asked of it is whether a brake on seizures the brain already uses can be imitated by a molecule small enough to get in 3

Sources

  1. Tatemoto et al., Galanin, a novel biologically active peptide from porcine intestine, FEBS Letters 1983
  2. Lang et al., Physiology, signalling and pharmacology of galanin peptides and receptors, Pharmacological Reviews 2015
  3. White et al., Characterization of NAX 5055, a systemically active galanin analogue, in epilepsy models, Neurotherapeutics 2009

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.